KZIA Kazia Therapeutics

$KZIA SABCS abstract titles: Abstract P4-9-18 “Paxalisib uniquely induces durable tumour and immune reprogramming across breast cancer subtypes, challenging the paradigm that dual PI3K/mTOR inhibitors are biologically equivalent.” * Presenting investigator: Sudha Rao * Institution: QIMR Berghofer Medical Research Institute, Herston, Australia * Session: Poster Session 4, December 10, 2026 * Official source: SABCS Poster Session 4⁠ Abstract P4-10-26 “Suppression of Local and Metastatic Recurrence by Adjuvant PI3K/mTOR Inhibition Through Durable Immune Epigenetic Rewiring Following Neoadjuvant Chemo-Immunotherapy in Stage III Triple-Negative Breast Cancer.” * Presenting investigator: Sudha Rao * Institution: QIMR Berghofer Medical Research Institute * Official source: SABCS Poster Session 4⁠

$KZIA Dauntless Investment Group filed an amended Schedule 13G/A reporting beneficial ownership of 842,340 KZIA ADSs, or 5.4% of the company, based on 15,598,889 ADSs outstanding. The ownership event occurred September 25 and the filing was accepted by the SEC today. This is notable because Dauntless had reported essentially exiting KZIA at the end of 2025—just 1 ADS / 0.0% in its February filing. Its 13F history then shows rebuilding the position to about 79,832 ADSs in Q1 2026 and 354,208 in Q2. The new 842,340-share disclosure therefore represents a substantial further increase.

$KZIA Last year, KZIA filed its annual financial results on Friday, November 7, 2025 so probably next week we should have one for this year . Still no FDA news .. it’s been long time…the latest public data shows 42 institutional holders and 8 analysts covering KZIa. ..

$KZIA Insanity. Kazia has over $5 per share in cash with a free call on future $ on execution of milestone(key word) warrants with an easy bogey at $17 plus and $19 plus. Pax with multiple shots on goal and protein degrader is for free. As Don King would say. "Only in America"

$KZIA well, I accumulated on dips. Quite the sweep. What a joke. Like Big Pharma and MMs are throwing a tantrum about not letting Kazia be a cheap acquisition.

$KZIA Existing investors in denial at the shameful way the company has treated them- while judging by the price action, others have just sold. Almost to the week, when the SP was moving & finally casting aside the shackles of years of additional stock dilution, what do they do....break disclosures of no more raises until 2028 ( despite $35m in cash), and flood the market with another up to 72% more stock. Multi issues abound as to the absolute stupidity of a raise now & the overhang the warrents create. The most historic, senseless and dumb decision ever recorded on a bouse-may not be an over statement. Why raise prior to a FDA meeting to discuss accelerated approval for GBM ? Independent of this woeful company, there is a very genuine chance of success. Spoon fed a golden opportunity in world standard work done for Paxalisib to treat Parkinson's - too busy ? we don't know, because they breach their continuous disclosure obligations, by not updating news on the PD collarbratorion.

$KZIA Big volume. Could we actually hit rock bottom today? Market not friendly but this valuation is so cheap. GBM data coming soon could be a pleasant surprise for shareholders. Eventually this worm turns...

$KZIA 1,174,118 is the new short interest as of 9/30 ..... So there you have it ..... It's getting heavily shorted.

$KZIA "Yes, Wall Street equity research analysts overwhelmingly rate Kazia Therapeutics (KZIA) as a Buy. Aggregate polling from major databases like Stock Analysis and The Wall Street Journal shows a unanimous consensus of "Strong Buy" or "Buy" among the 5 to 6 specialized institutional analysts actively covering the company." WTH is going on here? Who or what is driving this price down and why?

$KZIA Could get the 20F filing by Monday night. Perhaps even today at the close tonight is possible as a plausible guess

$KZIA So much disruption! Investors simply wish the company would stop disrupting the upwards trajectory of the stock price. A reasonable ask it would seem. Not pressuring the company to move quickly, just stop taking action to move backwards, suppressing the share price with gratuitous dilution under the guise of not wanting volatility; speculation. imo. And since they have decided they cannot walk and chew gum at the same time they seem to be avoiding any other applications upon which however they had eagerly raised investment dollars. This seems wrong. They are treating retail investors as adversaries. imo. And yet at the same time awarding management hundreds of thousands of share/options at preferred prices. And then claiming to be aligned with investors? Yeesh. That reeks. Nope not aligned. It is their little sandbox and you are not invited.

$KZIA "Under U.S. securities laws, "manipulation" has a very strict, narrow legal definition that requires proof of deception, fraud, or artificiality. Because institutional investors and corporate management operate under the umbrella of "corporate governance" and "influence," they can legally exert massive pressure on a stock's price and a company's direction without it ever crossing the legal threshold into manipulation. [1, 2, 3] This legal boundary creates an enormous gap between what the public perceives as "manipulation" and what the Securities and Exchange Commission (SEC) can actually prosecute."

$KZIA it's heading towards thanksgiving again and needs to explain why his Kazia investment hasn't generated generational wealth yet. It's been over 7 years 😆

$KZIA The company needs to get off its backside and WORK on behalf of shareholders. It is not difficult to immediately turn things around, with just a little bit of effort. That post yesterday of the medical group out of Basel who call for & publish research on PI3K mTOR and human disease. Right now, the company has to reach out and make paxalisib available to these credible scientists, for their ongoing studies. 23 research works had been published & more this year. Precident exists for a very informal agreement, in this situation. Kazia is NOT selling out rights to pAX, or even starting a trial - rather just fostering more initial human disease research, on the central human metabolic pathway, (PI3K mTOR)with the best drug in the world to inhibitor ( repair) disease damage. Cranky at having to type the obvious here - TELL THE MARKET of pAX research for ageing, Alzheimer's, mouth, cardiac, blood cancers & so on. But oh no they are too busy presently. It is a bad situation here.

$KZIA On Oct 27, 2025, Kazia announced it would Request a FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner. Specific FDA guidelines confirm a Type C meeting is typically scheduled about 75 days after the FDA receives the meeting request. QUOTE "This 75‑day scheduling timeline is specified in FDA guidance and applies broadly across Type C meetings..." Accelerated GBM approval may be forthcoming, when & if the company proceed with the Type C meeting. See below. But with Kazia, no news after a year, at what seems a major shareholder value driver. Including its Phase 2 GBM study & GBM AGILE, the company can present OS data in over 70 patients. FDA looking for positive biomarker results, but Kazia can do much better than that with real patient results.

$KZIA Faith $FTH and Celcuity $CELC our illustrious peer group leaders are down the limit. Suddenly the Kazia $ raise becomes a good transaction at $15.50 with de minimis dilution. Where is the ? Macro headwinds will may destroy the shitcos but Kazia has staying power to ride this storm out now

$KZIA down 50% and laughing. Short it right to 0.01 and I'll buy half the fucking company 😂

$KZIA Acting like an AI stock. Somebody knows something the average retails trader does not. For sure. Lots of pain on this one. But I am holding. Can only drop another $6!

$KZIA can’t even look at the account at this point. Valuation is lower then money in the bank. This is madness. We going to $5

$KZIA this is fucking insane as always...they better hire good management team and PR team..